In a different experiment using a mouse model induced with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to simulate PD, tDCS was found to decrease the levels of α-synuclein protein [87]. This evidence concerns the gene SNCA and Parkinson disease.